Skip to main content
SpringerLink
Log in

Mobilization of Blood Stem Cells with Recombinant Human (rh)G-CSF in Patients with Hematological Malignancies and Solid Tumors

  • Chapter
Peripheral Blood Stem Cell Autografts

Abstract

Peripheral blood stem cells (PBSC) are being increasingly used for autografting in patients with malignant diseases to circumvent the myelotoxic effects of high-dose therapy [1]. It is generally accepted that the kinetics of hematological recovery following autografting essentially depend on the number of hemopoietic stem cells transplanted [2, 3]. In the past, different methods have thus been explored to improve blood stem cell collection [4, 5].

This work was supported by Deutsche Krebshilfe e.V.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Kessinger A, Armitage JO (1991) The evolving role of autologous peripheral stem cell transplantation following high-dose therapy for malignancies. Blood 77: 211

    PubMed  CAS  Google Scholar 

  2. To LB, Dyson PG, Juttner CA (1986) Cell-dose effect in circulating stem-cell autografting. The Lancet 11: 404

    Article  Google Scholar 

  3. Fermand JP, Levy Y, Gerota J, Benbunan M, Cosset JM, Castaigne S, Seligmann M, Brouet JC (1989) Treatment of aggressive multiple myeloma by high dose chemotherapy and total body irradiation followed by blood stem cells autologous graft. Blood 73: 20

    PubMed  CAS  Google Scholar 

  4. Cline MJ, Golde DW (1977) Mobilization of hematopoietic stem cells ( CFU-C) into the peripheral blood of man by endotoxin. Exp Hematol 5: 186

    PubMed  CAS  Google Scholar 

  5. To LB, Shepperd KM, Haylock DN, Dyson PG, Charles P, Thorp DL, Dale BM, Dart GW, Roberts MM, Sage RE, Juttner CA (1990) Single high doses of cyclophosphamide enable the collection of high numbers of hemopoietic stem cells from the peripheral blood. Exp Hematol 18: 442

    PubMed  CAS  Google Scholar 

  6. Siena S, Bregni M, Brando B, Ravagnani F, Bonadonna G, Gianni AM (1989) Circulation of CD34+ hematopoietic stem cells in the peripheral blood of high-dose cyclophosphamide treated patients: Enhancement by intravenous recombinant human granulocyte- macrophage colony-stimulating factor. Blood 74: 1905

    PubMed  CAS  Google Scholar 

  7. Haas R, Ho AD, Bredthauer U, Cayeux S, Egerer G, Knauf W, Hunstein W (1990) Successful autologous transplantation of blood stem cells mobilized with recombinant human granulocyte-macrophage colony-stimulating factor. Exp Hematol 18: 94

    PubMed  CAS  Google Scholar 

  8. Haas R, Hohaus S, Egerer G, Ehrhardt R, Witt B, Hunstein W (1992) Recombinant human granulocyte-macrophage colony-stimulating factor (rhGM-CSF) subsequent to chemotherapy improves collection of blood stem cells for autografting in patients not eligible for bone marrow harvest. Bone Marrow Transplantation 9: 459

    PubMed  CAS  Google Scholar 

  9. Dührsen U, Villeval J-L, Boyd J, Kannourakis G, Morstyn G, Metcalf D (1988) Effects of recombinant human granulocyte colony-stimulating factor on hematopoietic progenitor cells in cancer patients. Blood 72: 2074

    PubMed  Google Scholar 

  10. Demuynck H, Pettengell R, de Campos E, Dexter TM, Testa NG (1992) The capacity of peripheral blood stem cells mobilised with chemotherapy plus G-CSF to repopulate irradiated marrow stroma in vitro is similar to that of bone marrow. Eur J Cancer 28: 381

    CAS  Google Scholar 

  11. Brugger W, Bross K, Frisch J, Dern P, Weber B, Mertelsmann R, Kanz L (1992) Mobilization of peripheral blood progenitor cells by sequential administration of interleukin-3 and granulocyte-macrophage colony-stimulating factor following polyche- motherapy with etoposide, ifosfamide, and cisplatin. Blood 79: 1193

    PubMed  CAS  Google Scholar 

  12. Berenson RJ, Bensinger WI, Hill RS, Andrews RG, Garcia-Lopez J, Kalamasz DF, Still BJ, Spitzer G, Buckner CD, Bernstein ID, Thomas ED (1991) Engraftment after infusion of CD34+ marrow cells in patients with breast cancer or neuroblastoma. Blood 77: 1717

    PubMed  CAS  Google Scholar 

  13. Sheridan WP, Begley CG, Juttner CA, Szer J, To LB, Mäher D, McGrath KM, Morstyn G, Fox RM (1992) Effect of peripheral-blood progenitor cells mobilised by filgrastim ( G-CSF) on platelet recovery after high-dose chemotherapy. The Lancet 339: 640

    Article  CAS  Google Scholar 

  14. Civin CI, Loken MR (1992) Cell surface antigens on human marrow cells: Dissection of hematopoietic development using monoclonal antibodies and multiparameter flow cytometry. In: Murphy MJ Jr (ed) Concise reviews in clinical and experimental hematology. Alpha Med Press, Dayton, Ohio, p 149

    Google Scholar 

  15. Sharp JG, Kessinger A, Vaughan WP, Mann S, Crouse DA, Dicke K, Masih A, Weisenburger DD (1992) Detection and clinical significance of minimal tumor cell contamination of peripheral stem cell harvests. Intern J Cell Cloning 10 (Suppl 1): 92

    Article  Google Scholar 

  16. Longlands K, Anderson JS, Parker AC, Anthony RS (1992) Polymerase chain reaction analysis of tumour contamination in peripheral blood stem cell harvests. Intern J Cell Cloning 10 (Suppl 1): 95

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Internal Medicine V, University of Heidelberg, Hospitalstr. 3, 6900, Heidelberg, Germany

    R. Haas, S. Hohaus, R. Ehrhardt, H. Goldschmidt, B. Witt & W. Hunstein

Authors
  1. R. Haas
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. S. Hohaus
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. R. Ehrhardt
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. H. Goldschmidt
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. B. Witt
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. W. Hunstein
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Service d’Hématologie et Institut de Recherche en Hématologie, Transfusion Hospital du Hasenrain, 87 av. d’Altkirch, 68051, Mulhouse Cedex, France

    Eckart W. Wunder M.D. (Médecin attaché Prof. assoc., Head of Stem Cell Laboratory) & Philippe R. Henon M.D. (Chef de Service Prof. assoc., Director of Research) (Médecin attaché Prof. assoc., Head of Stem Cell Laboratory) &  (Chef de Service Prof. assoc., Director of Research)

Rights and permissions

Reprints and permissions

Copyright information

© 1993 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Haas, R., Hohaus, S., Ehrhardt, R., Goldschmidt, H., Witt, B., Hunstein, W. (1993). Mobilization of Blood Stem Cells with Recombinant Human (rh)G-CSF in Patients with Hematological Malignancies and Solid Tumors. In: Wunder, E.W., Henon, P.R. (eds) Peripheral Blood Stem Cell Autografts. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-75717-4_16

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-75717-4_16

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-75719-8

  • Online ISBN: 978-3-642-75717-4

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation